RELEASE: Mindray Introduces Innovative Upgrades to A-Series Anesthesia Systems

Mindray Introduces Innovative Updates to A-Series Anesthesia Systems to Improve Patient Safety and Efficiency.

RELEASE: Mindray Introduces Innovative Upgrades to A-Series Anesthesia Systems

Mindray Introduces Innovative Updates to A-Series Anesthesia Systems to Improve Patient Safety and Efficiency

SHENZHEN, China, Aug. 30, 2023 /PRNewswire/ -- Mindray (SZSE: 300760), a world leader in providing advanced medical device solutions, has introduced upgrades to its A7 and A5 anesthesia systems under the A Series of Anesthesia. These enhancements incorporate innovative technologies that allow anesthesiologists to deliver precise anesthesia, leading to greater patient safety and efficiency throughout the perioperative period.

"The demand for higher quality and more diversified anesthesia practices is increasing. In response to this need, Mindray has developed the A7 and A5 anesthesia systems, which provide an integrated solution for the accurate and safe delivery of anesthesia to patients. with various conditions and an optimized management system for anesthesiologists," said Mark Sun, General Manager, Global Sales & Marketing, Patient Monitoring & Life Support at Mindray.

AnaeSight™ is Mindray's pioneering integrated solution for combined intravenous and inhalation anesthesia. By connecting machines, patient monitors and pumps, it enables centralized control of intravenous inhalation anesthetics. This allows anesthesiologists to easily administer anesthetics and monitor patient vital signs from multiple devices from one easy-to-use interface, ensuring comprehensive assessment of patient status and expediting anesthesia management. In addition, the AnaeSight™ eMAC™ indicator measures the combined pharmacological effects of multiple anesthetics, aiding in medication administration to help anesthesiologists make well-informed decisions. Centralized control, integrated evaluation, and the combined effect of drugs work together to effectively reduce the workload, minimize the risk of human error, improve the quality of anesthesia, and improve patient safety.

A machine specifically designed to help anesthesiologists provide optimal ventilation management, the Mindray A7 and A5 offer both intubated and non-intubated anesthesia options to meet the needs of all patients. In addition to the high flow nasal cannula (HFNC) found on other A-series anesthesia machines, the systems incorporate the HFJV for jet ventilation, particularly valuable in surgeries where airways are shared or when dealing with cases difficult airways. The use of jet ventilation can improve patient safety by maintaining oxygenation levels and creating a better surgical environment.

The systems include a lung recruitment tool and monitoring parameters to ensure accurate care during anesthesia, reduce the risk of perioperative lung injury, and improve patient outcomes.

The systems improve connectivity and efficiency by providing an overview of patient status in each operating room, giving anesthesiologists convenient access to real-time updates on patient vital sign status. In addition, the operational status of the devices is easily accessible, ensuring proper maintenance for clinical procedures.

Photo - https://mma.prnewswire.com/media/2195298...

View original content: https://www.prnewswire.com/news-releases/mindray-presenta-actualizaciones-innovadoras-a-los-sistemas-de-anestesia-de-serie-a-301912909.html

NEXT NEWS